Related Experiment Video
Updated: Jun 1, 2026
07:36
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Neonatal Graves' disease associated with severe metabolic abnormalities
Katherine A Lewis1, William Engle, Bryan E Hainline
1Department of aPediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA. lewis55@iupui.edu
Pediatrics
|June 8, 2011
Summary
Neonatal Graves' disease, a rare condition, can present with severe metabolic issues like conjugated hyperbilirubinemia and hyperammonemia in infants. This highlights the importance of considering this endocrine disorder in neonatal metabolic emergencies.
Area of Science:
- Neonatal endocrinology
- Pediatric metabolic disorders
- Clinical case studies
Background:
- Neonatal Graves' disease is a rare condition caused by transplacental transfer of maternal thyroid-stimulating immunoglobulin.
- It can manifest with multisystem abnormalities, potentially mimicking other serious neonatal conditions.
Observation:
- This report details two cases of infants diagnosed with neonatal Graves' disease.
- Both infants presented with significant metabolic derangements.
Findings:
- The observed metabolic abnormalities included conjugated hyperbilirubinemia and hyperammonemia.
- These findings underscore the potential for severe metabolic complications in neonatal Graves' disease.
Implications:
- Clinicians should consider neonatal Graves' disease in the differential diagnosis of infants with unexplained conjugated hyperbilirubinemia and hyperammonemia.
- Early recognition and management of neonatal Graves' disease are crucial to prevent severe outcomes.
Related Concept Videos
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...